The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhaled Nitric Oxide Delivery Device Market Research Report 2024
Synopsis
Due to the COVID-19 pandemic, the global Inhaled Nitric Oxide Delivery Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Inhaled Nitric Oxide Delivery Device market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Inhaled Nitric Oxide Delivery Device landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Inhaled Nitric Oxide Delivery Device for Children accounting for % of the Inhaled Nitric Oxide Delivery Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hypoxic Respiratory Failure (HRF) segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED and Bellerophon Therapeutics and etc. In terms of revenue, the global 3 largest players have a % market share of Inhaled Nitric Oxide Delivery Device in 2021.
This report focuses on Inhaled Nitric Oxide Delivery Device volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Inhaled Nitric Oxide Delivery Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Inhaled Nitric Oxide Delivery Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Segment by Application
Hypoxic Respiratory Failure (HRF)
Acute Hypoxemic Respiratory Failure (AHRF)
Chronic Obstructive Pulmonary Disease (COPD)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Mallinckrodt Pharmaceuticals
Getinge
Vero Biotech
LINDE
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
NU MED
Bellerophon Therapeutics
Praxair Technology Inc.
Due to the COVID-19 pandemic, the global Inhaled Nitric Oxide Delivery Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Inhaled Nitric Oxide Delivery Device market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Inhaled Nitric Oxide Delivery Device landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Inhaled Nitric Oxide Delivery Device for Children accounting for % of the Inhaled Nitric Oxide Delivery Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hypoxic Respiratory Failure (HRF) segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED and Bellerophon Therapeutics and etc. In terms of revenue, the global 3 largest players have a % market share of Inhaled Nitric Oxide Delivery Device in 2021.
This report focuses on Inhaled Nitric Oxide Delivery Device volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Inhaled Nitric Oxide Delivery Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Inhaled Nitric Oxide Delivery Device Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Segment by Application
Hypoxic Respiratory Failure (HRF)
Acute Hypoxemic Respiratory Failure (AHRF)
Chronic Obstructive Pulmonary Disease (COPD)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Mallinckrodt Pharmaceuticals
Getinge
Vero Biotech
LINDE
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
NU MED
Bellerophon Therapeutics
Praxair Technology Inc.
Index1 Inhaled Nitric Oxide Delivery Device Market Overview
1.1 Product Overview and Scope of Inhaled Nitric Oxide Delivery Device
1.2 Inhaled Nitric Oxide Delivery Device Segment by Type
1.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Inhaled Nitric Oxide Delivery Device for Children
1.2.3 Inhaled Nitric Oxide Delivery Device for Adults
1.3 Inhaled Nitric Oxide Delivery Device Segment by Application
1.3.1 Global Inhaled Nitric Oxide Delivery Device Sales Comparison by Application: (2022-2028)
1.3.2 Hypoxic Respiratory Failure (HRF)
1.3.3 Acute Hypoxemic Respiratory Failure (AHRF)
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Others
1.4 Global Inhaled Nitric Oxide Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Delivery Device Revenue 2017-2028
1.4.2 Global Inhaled Nitric Oxide Delivery Device Sales 2017-2028
1.4.3 Inhaled Nitric Oxide Delivery Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 Inhaled Nitric Oxide Delivery Device Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2017-2022)
2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Inhaled Nitric Oxide Delivery Device Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Inhaled Nitric Oxide Delivery Device Manufacturing Sites, Area Served, Product Type
2.5 Inhaled Nitric Oxide Delivery Device Market Competitive Situation and Trends
2.5.1 Inhaled Nitric Oxide Delivery Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Inhaled Nitric Oxide Delivery Device Players Market Share by Revenue
2.5.3 Global Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaled Nitric Oxide Delivery Device Retrospective Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Delivery Device Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Inhaled Nitric Oxide Delivery Device Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.3.1 North America Inhaled Nitric Oxide Delivery Device Sales by Country
3.3.2 North America Inhaled Nitric Oxide Delivery Device Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.4.1 Europe Inhaled Nitric Oxide Delivery Device Sales by Country
3.4.2 Europe Inhaled Nitric Oxide Delivery Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Region
3.5.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region
3.5.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.6.1 Latin America Inhaled Nitric Oxide Delivery Device Sales by Country
3.6.2 Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country
3.7.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Inhaled Nitric Oxide Delivery Device Historic Market Analysis by Type
4.1 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2022)
4.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2022)
4.3 Global Inhaled Nitric Oxide Delivery Device Price by Type (2017-2022)
5 Global Inhaled Nitric Oxide Delivery Device Historic Market Analysis by Application
5.1 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2022)
5.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2022)
5.3 Global Inhaled Nitric Oxide Delivery Device Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Getinge
6.2.1 Getinge Corporation Information
6.2.2 Getinge Description and Business Overview
6.2.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
6.2.5 Getinge Recent Developments/Updates
6.3 Vero Biotech
6.3.1 Vero Biotech Corporation Information
6.3.2 Vero Biotech Description and Business Overview
6.3.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
6.3.5 Vero Biotech Recent Developments/Updates
6.4 LINDE
6.4.1 LINDE Corporation Information
6.4.2 LINDE Description and Business Overview
6.4.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
6.4.5 LINDE Recent Developments/Updates
6.5 Beyond Air
6.5.1 Beyond Air Corporation Information
6.5.2 Beyond Air Description and Business Overview
6.5.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
6.5.5 Beyond Air Recent Developments/Updates
6.6 Air Liquide Healthcare
6.6.1 Air Liquide Healthcare Corporation Information
6.6.2 Air Liquide Healthcare Description and Business Overview
6.6.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
6.6.5 Air Liquide Healthcare Recent Developments/Updates
6.7 Circassia Pharmaceuticals
6.6.1 Circassia Pharmaceuticals Corporation Information
6.6.2 Circassia Pharmaceuticals Description and Business Overview
6.6.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
6.7.5 Circassia Pharmaceuticals Recent Developments/Updates
6.8 NU MED
6.8.1 NU MED Corporation Information
6.8.2 NU MED Description and Business Overview
6.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
6.8.5 NU MED Recent Developments/Updates
6.9 Bellerophon Therapeutics
6.9.1 Bellerophon Therapeutics Corporation Information
6.9.2 Bellerophon Therapeutics Description and Business Overview
6.9.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
6.9.5 Bellerophon Therapeutics Recent Developments/Updates
6.10 Praxair Technology Inc.
6.10.1 Praxair Technology Inc. Corporation Information
6.10.2 Praxair Technology Inc. Description and Business Overview
6.10.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
6.10.5 Praxair Technology Inc. Recent Developments/Updates
7 Inhaled Nitric Oxide Delivery Device Manufacturing Cost Analysis
7.1 Inhaled Nitric Oxide Delivery Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhaled Nitric Oxide Delivery Device
7.4 Inhaled Nitric Oxide Delivery Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhaled Nitric Oxide Delivery Device Distributors List
8.3 Inhaled Nitric Oxide Delivery Device Customers
9 Inhaled Nitric Oxide Delivery Device Market Dynamics
9.1 Inhaled Nitric Oxide Delivery Device Industry Trends
9.2 Inhaled Nitric Oxide Delivery Device Market Drivers
9.3 Inhaled Nitric Oxide Delivery Device Market Challenges
9.4 Inhaled Nitric Oxide Delivery Device Market Restraints
10 Global Market Forecast
10.1 Inhaled Nitric Oxide Delivery Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhaled Nitric Oxide Delivery Device by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Inhaled Nitric Oxide Delivery Device by Type (2023-2028)
10.2 Inhaled Nitric Oxide Delivery Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhaled Nitric Oxide Delivery Device by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Inhaled Nitric Oxide Delivery Device by Application (2023-2028)
10.3 Inhaled Nitric Oxide Delivery Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhaled Nitric Oxide Delivery Device by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Inhaled Nitric Oxide Delivery Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Inhaled Nitric Oxide Delivery Device Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Inhaled Nitric Oxide Delivery Device Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Inhaled Nitric Oxide Delivery Device Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Inhaled Nitric Oxide Delivery Device Market Competitive Situation by Manufacturers in 2021
Table 5. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Inhaled Nitric Oxide Delivery Device Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Inhaled Nitric Oxide Delivery Device Manufacturing Sites and Area Served
Table 11. Manufacturers Inhaled Nitric Oxide Delivery Device Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Inhaled Nitric Oxide Delivery Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled Nitric Oxide Delivery Device as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 16. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2022)
Table 17. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2022)
Table 19. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 20. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2022)
Table 21. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2022)
Table 23. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 24. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2022)
Table 25. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2022)
Table 31. Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2022)
Table 33. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2022)
Table 39. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 40. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2022)
Table 41. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2017-2022)
Table 43. Global Inhaled Nitric Oxide Delivery Device Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) by Application (2017-2022)
Table 45. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2022)
Table 46. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2017-2022)
Table 48. Global Inhaled Nitric Oxide Delivery Device Price by Application (2017-2022) & (US$/Unit)
Table 49. Mallinckrodt Pharmaceuticals Corporation Information
Table 50. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 51. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product
Table 53. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 54. Getinge Corporation Information
Table 55. Getinge Description and Business Overview
Table 56. Getinge Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Getinge Inhaled Nitric Oxide Delivery Device Product
Table 58. Getinge Recent Developments/Updates
Table 59. Vero Biotech Corporation Information
Table 60. Vero Biotech Description and Business Overview
Table 61. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Vero Biotech Inhaled Nitric Oxide Delivery Device Product
Table 63. Vero Biotech Recent Developments/Updates
Table 64. LINDE Corporation Information
Table 65. LINDE Description and Business Overview
Table 66. LINDE Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. LINDE Inhaled Nitric Oxide Delivery Device Product
Table 68. LINDE Recent Developments/Updates
Table 69. Beyond Air Corporation Information
Table 70. Beyond Air Description and Business Overview
Table 71. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Beyond Air Inhaled Nitric Oxide Delivery Device Product
Table 73. Beyond Air Recent Developments/Updates
Table 74. Air Liquide Healthcare Corporation Information
Table 75. Air Liquide Healthcare Description and Business Overview
Table 76. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product
Table 78. Air Liquide Healthcare Recent Developments/Updates
Table 79. Circassia Pharmaceuticals Corporation Information
Table 80. Circassia Pharmaceuticals Description and Business Overview
Table 81. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product
Table 83. Circassia Pharmaceuticals Recent Developments/Updates
Table 84. NU MED Corporation Information
Table 85. NU MED Description and Business Overview
Table 86. NU MED Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. NU MED Inhaled Nitric Oxide Delivery Device Product
Table 88. NU MED Recent Developments/Updates
Table 89. Bellerophon Therapeutics Corporation Information
Table 90. Bellerophon Therapeutics Description and Business Overview
Table 91. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product
Table 93. Bellerophon Therapeutics Recent Developments/Updates
Table 94. Praxair Technology Inc. Corporation Information
Table 95. Praxair Technology Inc. Description and Business Overview
Table 96. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product
Table 98. Praxair Technology Inc. Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Inhaled Nitric Oxide Delivery Device Distributors List
Table 102. Inhaled Nitric Oxide Delivery Device Customers List
Table 103. Inhaled Nitric Oxide Delivery Device Market Trends
Table 104. Inhaled Nitric Oxide Delivery Device Market Drivers
Table 105. Inhaled Nitric Oxide Delivery Device Market Challenges
Table 106. Inhaled Nitric Oxide Delivery Device Market Restraints
Table 107. Global Inhaled Nitric Oxide Delivery Device Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Inhaled Nitric Oxide Delivery Device Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Inhaled Nitric Oxide Delivery Device Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Inhaled Nitric Oxide Delivery Device Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Inhaled Nitric Oxide Delivery Device Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Inhaled Nitric Oxide Delivery Device Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Inhaled Nitric Oxide Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Inhaled Nitric Oxide Delivery Device Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Inhaled Nitric Oxide Delivery Device Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhaled Nitric Oxide Delivery Device
Figure 2. Global Inhaled Nitric Oxide Delivery Device Market Share by Type in 2021 & 2028
Figure 3. Inhaled Nitric Oxide Delivery Device for Children Product Picture
Figure 4. Inhaled Nitric Oxide Delivery Device for Adults Product Picture
Figure 5. Global Inhaled Nitric Oxide Delivery Device Market Share by Application in 2021 & 2028
Figure 6. Hypoxic Respiratory Failure (HRF)
Figure 7. Acute Hypoxemic Respiratory Failure (AHRF)
Figure 8. Chronic Obstructive Pulmonary Disease (COPD)
Figure 9. Others
Figure 10. Global Inhaled Nitric Oxide Delivery Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Inhaled Nitric Oxide Delivery Device Market Size (2017-2028) & (US$ Million)
Figure 12. Global Inhaled Nitric Oxide Delivery Device Sales (2017-2028) & (K Units)
Figure 13. Inhaled Nitric Oxide Delivery Device Sales Share by Manufacturers in 2021
Figure 14. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Inhaled Nitric Oxide Delivery Device Players: Market Share by Revenue in 2021
Figure 16. Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2022)
Figure 18. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region in 2021
Figure 19. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2022)
Figure 20. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region in 2021
Figure 21. United States Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Inhaled Nitric Oxide Delivery Device by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Inhaled Nitric Oxide Delivery Device
Figure 45. Manufacturing Process Analysis of Inhaled Nitric Oxide Delivery Device
Figure 46. Inhaled Nitric Oxide Delivery Device Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
